| Literature DB >> 34401195 |
Michael Rosenbaum1, Robert Garofano1, Kalle Liimatta1, Kerry McArthur1, Erin Paul1, Thomas Starc1, Aviva B Sopher1, Vidhu Thaker1, Jennifer Woo Baidal1.
Abstract
BACKGROUND: Obesity affects ∼17% of US children, with parallel increases in multiple comorbidities, especially among African-, Asian-, Hispanic-, and Native-Americans. Barriers to patient retention in pediatric obesity programs include lack of centralized care, and frequent subspecialty MD visits which conflict with patient school attendance and parental work attendance as well as with support service utilization. Lack of integration of multispecialty clinical care with interdisciplinary research is a major barrier to fuller exploration of the treatment, prevention, and understanding of obesity in childhood.Entities:
Keywords: child; interdisciplinary research; multispecialty treatment; obesity
Year: 2021 PMID: 34401195 PMCID: PMC8346376 DOI: 10.1002/osp4.498
Source DB: PubMed Journal: Obes Sci Pract ISSN: 2055-2238
FIGURE 1Initial laboratory screening. Routine fasting laboratory testing was done every 6–12 months unless the severity of a detected abnormal result (e.g., elevated glycosylated hemoglobin or thyroid disease) indicates the need for more frequent sampling
FIGURE 2Outline of exercise intervention. The goal of this intervention was to give participants the knowledge to engage regularly in physical activity and acquaint them with the opportunities to do so in their communities
Mean (SD) and range of participant demographics
| Demographics | All ( | Males ( | Females ( | |
|---|---|---|---|---|
| Age (years) – Mean (SD) | 6.6 (2.4) | 6.6 (2.0) | 6.9 (2.4) | |
| Range | 2.3–11.2 | 2.3–10.5 | 3.1–11.2 | |
| Age distribution (years) | 2–4 | 22, 28% | 13, 32% | 9, 24% |
| ( | 5–7 | 36, 45% | 18, 44% | 18, 47% |
| 8–10 | 19, 24% | 10, 24% | 9, 24% | |
| 11 | 2, 3% | 0, 0% | 2, 5% | |
| BMI – Mean (SD) | 27.5 (5.3) | 27.1 (4.5) | 26.9 (5.69) | |
| Range | 20.0–36.5 | 20.0–37.3 | 22.5–36.5 | |
| BMI % of the 95%ile – Mean (SD)Range | 135.2 (19.8) | 141.8 (22.1) | 130.6 (16.3) | |
| 105.9–193.2 | 105.9–193.2 | 108.5–176.0 | ||
| One or more parents with obesity*
| 44, 56% | 21, 51% | 23, 60% | |
*Self‐reported.
Data available on only one parent in 35% of participants.
FIGURE 3Annual household income (self‐reported)
Mean (SD) values related to co‐morbidities and percentage classified as having adiposity‐related co‐morbidities
| Adiposity‐related comorbidities | All ( | Males ( | Females ( | % abnormal | Definition | |
|---|---|---|---|---|---|---|
| Systolic BP | 104 (10) | 105 (11) | 104 (10) | 43% ( | >90%ile for age and sex | |
| Diastolic BP | 65 (8) | 66 (7) | 64 (8) | 39% ( | ||
| Glucose (mg/dl) | 85 (7) | 86 (7) | 84 (8) | 0% ( | >100 | |
| Insulin (mIU/ml) | 12.4 (8.9) | 11.9 (9.6) | 12.8 (8.4) | 66% ( | >7.0 | |
| Hba1C | 5.1 (0.3) | 5.2 (0.3) | 5.1 (0.3) | 6% ( | >5.7 | |
| Cholesterol (mg/dl) | Total | 156 (34) | 165 (40) |
| 36% ( | >170 |
| Triglyceride | 99 (54) | 89 (50) | 108 (56) | 56% ( | >75 | |
| HDL | 47 (11) | 50 (13) | 44 (10) | 19% ( | <35 | |
| LDL | 89 (27) | 98 (31) |
| 25% ( | >100 | |
| Vitamin D (ng/ml) | 24.9 (6.5) | 24.3 (7.8) | 25.3 (5.2) | 83% | <30 | |
| AST (U/L) | 29.3 (11.7) | 30.2 (14.7) | 28.5 (8.2) | 17% ( | >90%ile for age and sex | |
| ALT (U/L) | 22.6 (14.3) | 21.7 (14.2) | 24.4 (14.4) | 14% ( | ||
| Alkaline phosphatase (U/L) | 275 (68) | 248 (48) |
| 30% ( | ||
Note: Statistically significant differences from males are highlighted in bold.
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase.
p < 0.05 versus males.
55.6% of the participants were vitamin D insufficient (20 ng/ml < 25‐hydroxy vitamin D < 30 ng/ml) and 18.5% were vitamin D deficient (25‐hydroxyl vitamin D < 20 ng/ml).
Correlations of adiposity‐related co‐morbidity assessments and adiposity measured by BMI % above the 95%ile
| Adiposity and comorbidity correlations |
|
|
|---|---|---|
| Variable | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total cholesterol (mg/dl) | 0.15 | 0.28 |
| Triglycerides (mg/dl) | 0.05 | 0.82 |
| HDL cholesterol (mg/dl) | 0.02 | 0.84 |
| LDL cholesterol (mg/dl) | 0.15 | 0.17 |
| Vitamin D (ng/ml) | −0.23 | 0.06 |
| AST (U/L) | −0.15 | 0.16 |
| ALT (U/L) | 0.06 | 0.64 |
| Alkaline phosphatase (U/L) | −0.12 | 0.35 |
Note: Statistically significant correlations are highlighted in bold.
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase.
FIGURE 4Number of visits completed by subjects. The initial visits with the physician and dietitian were classified as visit 1. Subsequent visits were defined as meeting with the primary care obesity MD and/or with the dietitian after the initial meeting. A return appointment for fasting blood tests obtained by a phlebotomist was not counted as a clinical visit and subjects who did not return for fasting blood work were considered as having had only one visit. All subjects had the opportunity to complete at least two visits and only 9% of subjects (orange segment) failed to do so. Those enrolled earlier had the opportunity to complete more visits. All subjects were enrolled for a sufficient period of time to generate at least two visits